Carrier screening market size to grow by USD 2.36 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The global carrier screening market size is estimated to increase by USD 2.36 billion from 2021 to 2026. The market's growth momentum will accelerate at a CAGR of 17.66%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Discover more insights on market size before buying the full report - Request a sample report

Carrier screening market – Vendor analysis
Vendor offerings -

• Abbott Laboratories - The company offers carrier screening for rapid detection of aneusomy in amniotic fluid samples, under the brand name Vysis.
• Danaher Corp. - The company offers carrier screening that detects the genetic risk for thrombosis, under the brand name Xpert.
• DiaSorin SpA - The company offers carrier screening that detects whether a patient or their partner carries pathogenic mutations associated with certain X-linked genetic disorders, under the brand name Eurofins NTD.
• F. Hoffmann La Roche Ltd. - The company offers carrier screening and helps patients with late-stage or hard-to-treat cancers, under the brand name Roche.
• For details on vendors and their offerings – Buy the report!

Vendor landscape –

The global carrier screening market is fragmented, with the presence of several well-established vendors. A few prominent vendors that offer carrier screening in the market are Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. and others.

Major market players are focusing on developing innovative products and are increasing their R&D investments. The established vendors have started acquiring smaller and regional players to enhance their global reach. In addition, the market will witness the entry of several new players, which will intensify the level of competition among the existing players during the forecast period.

Carrier screening market - Customer Landscape
To help companies evaluate and develop growth strategies, the report outlines –

• Key purchase criteria
• Adoption rates
• Adoption lifecycle
• Drivers of price sensitivity

Carrier screening market - Segmentation assessment

Segment overview
Technavio has segmented the market based on type (expanded carrier screening and targeted disease carrier screening). 

• The expanded carrier screening segment will account for a significant share of the market's growth during the forecast period. Expanded carrier screening refers to the identification of carriers of single-gene disorders outside of traditional screening guidelines. This allows the screening of multiple genetic conditions at the same time. Advances in the expanded carrier screening segment, such as Sema4 Elements Expanded Carrier Screen (ECS) with Personalized Residual Risk solution of Sema4 OpCo, Inc, will increase the demand for expanded carrier screening. This, in turn, is expected to fuel the growth of the segment during the forecast period.

Geography overview
Based on geography, the global carrier screening market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global carrier screening market.

• North America will account for 37% of the market's growth during the forecast period. The US is a key contributor to the carrier screening market in the region. Moreover, market growth in North America will be faster than the growth of the market in Europe. Growing concerns regarding early disease diagnosis, the rise in commercial approvals for advanced carrier screening, and the increasing use of pharmacogenomic testing will drive the carrier screening market growth in the region during the forecast period.

Download a sample report

Carrier screening market – Market dynamics

Leading drivers - The rising prevalence of genetic diseases and disorders such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia is driving the growth of the market. The increasing incidence of disabilities in newborns has fueled the adoption of prenatal testing. According to the CDC, about 3% of babies born in the US every year have birth defects. Parents with inheritable genetic conditions, such as autosomal dominant and recessive disorders, prefer early disease diagnosis through prenatal testing procedures. Such factors are expected to have a positive impact on the market growth during the forecast period.

Key trends – The use of next-generation sequencing (NGS) technology in carrier screening is a key trend in the market. NGS enables large-scale sequencing of the human genome to detect mutations and gene variants that can cause diseases. The long-read sequencing technology enables end-users to perform sequencing reads between 10,000 and 900,000 base pairs. Some of the key innovators in this field are vendors such as Illumina, Thermo Fisher Scientific, and QIAGEN. These factors will support the growth of the market during the forecast period.

Major challenges - Varying regulations on carrier screening and research globally are challenging the market's growth. Various regulatory authorities, such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), International Organization for Standardization (ISO), have enforced stringent and complex mandates on carrier screening. However, there are several variations in these, which can lead to compliance issues. This affects the business operations of vendors that operate globally, which, in turn, is expected to negatively impact the market growth during the forecast period.

Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this carrier screening market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the carrier screening market between 2022 and 2026
• Precise estimation of the size of the carrier screening market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the carrier screening market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of carrier screening market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The cellular health screening market size is expected to increase by USD 1.92 billion from 2021 to 2026 at a CAGR of 11.24%. This report extensively covers market segmentation by channel (office, hospital, diagnostic labs, home, and others) and geography (North America, Europe, APAC, and Rest of World (ROW)).

The microbiology testing market is estimated to grow at a CAGR of 9.98% between 2022 and 2027. The size of the market is forecasted to increase by USD 3,012.8 million. This report extensively covers market segmentation by method (traditional, rapid, and molecular), product (consumable and instruments), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others), and geography (North America, Europe, Asia, and Rest of World).

Browse for Technavio's health care market reports

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments 
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

• 5.2 Comparison by Type 
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type

• 5.3 Expanded carrier screening - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Expanded carrier screening - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Expanded carrier screening - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Expanded carrier screening - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Expanded carrier screening - Year-over-year growth 2021-2026 (%)

• 5.4 Targeted disease carrier screening - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Targeted disease carrier screening - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Targeted disease carrier screening - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Targeted disease carrier screening - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Targeted disease carrier screening - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Type 
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 Japan - Market size and forecast 2021-2026
• Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Abbott Laboratories 
• Exhibit 85: Abbott Laboratories - Overview
• Exhibit 86: Abbott Laboratories - Business segments
• Exhibit 87: Abbott Laboratories - Key news
• Exhibit 88: Abbott Laboratories - Key offerings
• Exhibit 89: Abbott Laboratories - Segment focus

• 10.4 Danaher Corp. 
• Exhibit 90: Danaher Corp. - Overview
• Exhibit 91: Danaher Corp. - Business segments
• Exhibit 92: Danaher Corp. - Key news
• Exhibit 93: Danaher Corp. - Key offerings
• Exhibit 94: Danaher Corp. - Segment focus

• 10.5 Eurofins Scientific SE 
• Exhibit 95: Eurofins Scientific SE - Overview
• Exhibit 96: Eurofins Scientific SE - Business segments
• Exhibit 97: Eurofins Scientific SE - Key news
• Exhibit 98: Eurofins Scientific SE - Key offerings
• Exhibit 99: Eurofins Scientific SE - Segment focus

• 10.6 F. Hoffmann La Roche Ltd. 
• Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus

• 10.7 Fulgent Genetics 
• Exhibit 105: Fulgent Genetics - Overview
• Exhibit 106: Fulgent Genetics - Business segments
• Exhibit 107: Fulgent Genetics - Key offerings
• Exhibit 108: Fulgent Genetics - Segment focus

• 10.8 Illumina Inc. 
• Exhibit 109: Illumina Inc. - Overview
• Exhibit 110: Illumina Inc. - Product / Service
• Exhibit 111: Illumina Inc. - Key offerings

• 10.9 Invitae Corp. 
• Exhibit 112: Invitae Corp. - Overview
• Exhibit 113: Invitae Corp. - Product / Service
• Exhibit 114: Invitae Corp. - Key offerings

• 10.10 OPKO Health Inc. 
• Exhibit 115: OPKO Health Inc. - Overview
• Exhibit 116: OPKO Health Inc. - Business segments
• Exhibit 117: OPKO Health Inc. - Key news
• Exhibit 118: OPKO Health Inc. - Key offerings
• Exhibit 119: OPKO Health Inc. - Segment focus

• 10.11 Quest Diagnostics Inc. 
• Exhibit 120: Quest Diagnostics Inc. - Overview
• Exhibit 121: Quest Diagnostics Inc. - Business segments
• Exhibit 122: Quest Diagnostics Inc. - Key offerings
• Exhibit 123: Quest Diagnostics Inc. - Segment focus

• 10.12 Thermo Fisher Scientific Inc. 
• Exhibit 124: Thermo Fisher Scientific Inc. - Overview
• Exhibit 125: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 126: Thermo Fisher Scientific Inc. - Key news
• Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 128: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 129: Inclusions checklist
• Exhibit 130: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 131: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 132: Research methodology
• Exhibit 133: Validation techniques employed for market sizing
• Exhibit 134: Information sources

• 11.5 List of abbreviations 
• Exhibit 135: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED